Protective Effect of Nasal Drops in COVID Infectio
Phase 1
Not yet recruiting
- Registration Number
- CTRI/2021/06/034061
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Individuals 20-60 years of age.
2. Healthy
3. The participant must have normal hemogram,
4. No systemic disease,
5. Agree not to self-medicate with other potential antivirals during the course of the study.
6. The participant must have the ability to use the product as directed
7. Participant must have the willingness
8. Participant must have ability to understand the nature of trial and the follow-up procedures.
Exclusion Criteria
1. History of COVID-19 infection within 90 days
2. History of helminthic infection,
3. History of diabetes or any other systemic disease
4. Individuals who are symptomatic or convalescent.
5. Individuals who are on other prophylactic/s
6. Individuals who do not have the ability and willingness to use the product.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in Viral LoadTimepoint: 28 days
- Secondary Outcome Measures
Name Time Method Free from disease <br/ ><br>If infected, they will have mild symptomsTimepoint: 3 Months